NEW YORK, NY — (Marketwire) — 03/11/13 — TriMarkPublications.com cites in its newly published ” Markets” report that the market will spike to $1.6 billion by 2017. For more information, visit:
can be categorized into three main modalities: clinical laboratory HbA1c testing, point of care HbA1c testing and physician office laboratories (POL) HbA1c testing. The POC segment occupies nearly one third of the total market and is one of the fastest growing areas, with a CAGR of 12.7% between 2012 and 2017. The U.S. market is projected to grow to $518 million in 2017. Combined, the developed regions comprise greater than 75% of the total market.
The ” Markets” report covers:
Diabetes
Pre-Diabetes Syndrome
Metabolic Syndrome
High-Performance Liquid Chromatography (HPLC)
Immunoassays
Boronate Affinity Chromatography
Enzymatic Assay
Micro-Optical Detection Methods
Diabetes Control and Complications Trial (DCCT)
National Glycohemoglobin Standardization Program (NGSP)
International Federation of Clinical Chemistry (IFCC)
A1c Derived Average Glucose (ADAG)
The ” Markets” report examines companies manufacturing equipment and supplies in the world. Companies covered include: A. Menarini, Abbott, Alere, Arkray, Axis-Shield, Bayer Healthcare, Beckman Coulter, Bio-Rad, EKF, Infopia, Ortho Clinical, Quotient, Randox, Roche, Siemens, Tosoh and Trinity.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK